# V1 Empirics Check — x-ai/grok-4.1-fast (Variant A)

**Model:** x-ai/grok-4.1-fast
**Variant:** A
**Date:** 2026-03-27T17:03:33.949502

---

### 1. Idea Fidelity

The paper largely pursues the original idea of causally evaluating staggered state workplace violence prevention (WVP) mandates on healthcare worker injuries using OSHA ITA 300A data and Callaway-Sant'Anna (CS) staggered DiD. It faithfully employs CS DiD with never-treated states as controls and includes a placebo on non-healthcare establishments. However, it misses key elements: (i) outcomes are total days-away-from-work (DAFW) injuries, not violence-specific assaults using OIICS event codes from case-detail data (available 2023+), diluting the link to the policy; (ii) it analyzes only 14 treated states (2017-2023) versus the manifest's 27+ states (2011-2027), classifying early (e.g., CT 2011/2012) and late (e.g., TX 2024, NY 2027) adopters as never-treated; and (iii) no placebo using non-violence injuries within healthcare. Data ends at 2023 (not 2024), and establishment-level granularity is aggregated to state-year.

### 2. Summary

This paper exploits staggered adoption of healthcare-specific WVP mandates in 14 U.S. states (2017-2023) to estimate their impact on DAFW injury rates using state-by-year aggregates from OSHA ITA 300A data (2016-2023, NAICS 62 healthcare establishments). Employing CS staggered DiD with never-treated states as controls, it finds a precisely estimated null effect in the preferred specification excluding anomalous 2023 data (-0.11 injuries per 100 FTE workers, SE=0.50). Robustness checks, including event studies, TWFE with trends, log outcomes, and non-healthcare placebos, support the null, attributing full-sample positives to data artifacts and state trends rather than mandates.

### 3. Essential Points

1. **Outcome-policy mismatch undermines identification**: The primary outcome (total DAFW rate) captures all serious injuries, not violence-specific assaults targeted by WVP mandates (e.g., OIICS code 11). This conflates prevention effects with reporting incentives (mandates require incident logging) and unrelated injuries (e.g., slips). Without violence-specific measures from case-detail data (as planned in the manifest), the null cannot credibly inform on mandate efficacy for assaults. Authors must either (i) incorporate OIICS-filtered violence events (feasible post-2023) or (ii) explicitly bound reporting effects (e.g., via pre-trends in reporting volume); otherwise, revise claims about "workplace safety outcomes."

2. **Subset of treatments and heterogeneous timing weaken design**: Limiting to 14 mid-period states (excluding 13+ early/late from manifest) risks selection bias, as early adopters (e.g., CT, CA pilots) may differ systematically. Singleton cohorts (e.g., CA 2017, WA 2019) amplify bias in CS aggregation. Event-study pre-trends show a significant lead at e=-1 (+1.10, p<0.05), violating parallel trends. Authors must extend to full 27+ states (using leads/lags for out-of-sample), test anticipation, and report cohort-specific ATTs with honest confidence bands (e.g., via Sun/Abraham bounds).

3. **Overreliance on 2023 exclusion without justification**: The "preferred" null hinges on dropping 2023 (and its cohort), but full-sample CS shows +3.93 (p<0.05), with post-treatment dynamics growing to +10.57 at e=+4. Placebo failures (non-HC +1.29, p<0.01) suggest confounding state trends, not just "data artifacts." Validate via external BLS data or imputation; if unresolvable, the design lacks credibility for a powered null.

### 4. Suggestions

**Data and Measurement**: Disaggregate beyond state-year to establishment- or county-year levels (~280k observations) to boost power, sharpen clustering (e.g., state-NAICS-time), and test establishment-size heterogeneity (mandates exempt small firms). Compute violence proxies pre-2023 via NAICS subcodes (e.g., psychiatric hospitals, NAICS 6222) or BLS SOII supplements. Standardize controls: add state demographics (e.g., opioid prescriptions per capita, elderly share), COVID indicators (2020-2023 violence spikes), and staffing ratios from CMS/AHRQ. Table 1 should include covariate balance tests (e.g., normalized differences <0.25) and visualize pre-trends by treated/control terciles.

**Identification Refinements**: Implement full CS suite: report ATT(g,t) matrix, dynamic event studies with 95% CI bands (not pointwise), and aggregator weights to flag bias from late-treated units. Augment with Sun/Abraham (2021) event-study for cleaner dynamics. For DDD, stack HC/non-HC panels explicitly (current Table 3 is incomplete); extend placebo to HC non-violence injuries if OIICS integrated. Test spillovers: diff-in-diff on border pairs (e.g., NJ-NY). Address small n=14 treated via leave-k-out (k=2-3 cohorts) and synthetic controls (Abadie et al. 2010) as complement.

**Robustness Expansion**: Quantify precision: report minimum detectable effects (MD E=0.5*SE*sqrt(N)) and power curves. For logs, use inverse-hyperbolic sine for zeros. Wild bootstrap all CS specs (not just TWFE). Heterogeneity: by subsector (hospitals vs. nursing), cohort (early vs. late), enforcement (state-OSHA plans), or baseline violence (high vs. low). Mechanism tests: regress post-mandate reporting volume (total cases) on treatment to decompose prevention vs. detection.

**Presentation and Interpretation**: Abstract/Intro: Clarify 14 vs. 27+ states; lead with policy stakes (e.g., "$X billion in costs"). Table 1: Add post-treatment stats, p-values for treated-control diffs. Event study (Table 2): Plot with CI bands; normalize to e=-1=0. Main table: Stars consistent across panels; add N, R^2. Discussion: Formalize "compliance without prevention" via model sketch (e.g., employer cost-min: min{training cost, fine prob} s.t. plan checkbox). Bound policy implications: "Rules out effects >25% of mean, but underpowered for small/subgroup shifts." Appendix: Full code, data appendix with treatment dates table (timeline plot), SDE table already strong—extend to subgroups.

**Broader Fit for AER:Insights**: Emphasize novelty (first causal WVP eval) and bounds (rules out large effects). Trim institutional background (merge subsections); target 20 pages. Lit review: Cite more DiD pitfalls (Roth 2022). JEL/keywords spot-on. Overall, strong execution of a timely quasi-experiment; addressing essentials could yield a publishable null with clear welfare implications (e.g., pivot to staffing mandates).
